Home
Dashboard
Curated content

Startups & Scaleups
Corporates
Investors
Funding rounds
Exits

Accelerators
Workspaces
Universities
Service providers
More organizations

Matching tool
Investment heatmap
Themes

News

Powered by

dealroom.co

Contact
FAQ
Privacy

Companies
Kadmon
Team
Team

Kadmon

Developing therapies for immune disorders, fibrotic diseases and cancer. Learn more

Launch date

2009

Employees

Market cap

-

Enterprise valuation

€1.7b (Public information from Sep 2021)

Share price

$9.5 KDMN

New York City New York (HQ)

http://kadmon.com

https://twitter.com/kadmon https://www.linkedin.com/company/kadmon-corporation-llc

B2B
health
biotechnology

hard tech
biotechnology
biotech and pharma
verified unicorns and $1b exits
post ipo $1b

Authorizing premium user...